Studies in breastfeeding women have shown that tirzepatide isnt transferred into human breast milk in meaningful amounts
more information go to www.p65warnings.ca.gov/fact-sheets/foods
What Are Pharmacokinetic Advantages of FOXO4-DRI
Weight loss outcomes : Semaglutide at the doses used for weight management (Wegovy, 2.4 mg weekly) has produced average weight loss of 15-17% of body weight over 68 weeks in clinical trials (STEP program)
Eur J Heart Fail 19(1):6977 Lepore JJ, Olson E, Demopoulos L, Haws T, Fang Z, Barbour AM, Fossler M, Davila-Roman VG, Russell SD, Gropler RJ (2016) Effects of the novel long-acting GLP-1 agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction